Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $5.45 billion. The enterprise value is $5.39 billion.
Important Dates
The last earnings date was Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 60.34 million shares outstanding. The number of shares has increased by 5.63% in one year.
| Current Share Class | 60.34M |
| Shares Outstanding | 60.34M |
| Shares Change (YoY) | +5.63% |
| Shares Change (QoQ) | -11.92% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 90.89% |
| Float | 52.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.46 |
| Forward PS | 8.52 |
| PB Ratio | 14.48 |
| P/TBV Ratio | 101.42 |
| P/FCF Ratio | 99.38 |
| P/OCF Ratio | 97.68 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 2,556.55, with an EV/FCF ratio of 98.21.
| EV / Earnings | n/a |
| EV / Sales | 10.34 |
| EV / EBITDA | 2,556.55 |
| EV / EBIT | n/a |
| EV / FCF | 98.21 |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 1.02.
| Current Ratio | 2.67 |
| Quick Ratio | 2.46 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 70.86 |
| Debt / FCF | 5.82 |
| Interest Coverage | -1.54 |
Financial Efficiency
Return on equity (ROE) is -8.65% and return on invested capital (ROIC) is -2.35%.
| Return on Equity (ROE) | -8.65% |
| Return on Assets (ROA) | -1.83% |
| Return on Invested Capital (ROIC) | -2.35% |
| Return on Capital Employed (ROCE) | -3.47% |
| Weighted Average Cost of Capital (WACC) | 6.89% |
| Revenue Per Employee | $1.40M |
| Profits Per Employee | -$62,804 |
| Employee Count | 372 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 4.24 |
Taxes
In the past 12 months, MIRM has paid $1.94 million in taxes.
| Income Tax | 1.94M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.50% in the last 52 weeks. The beta is 0.52, so MIRM's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +96.50% |
| 50-Day Moving Average | 93.23 |
| 200-Day Moving Average | 70.53 |
| Relative Strength Index (RSI) | 38.95 |
| Average Volume (20 Days) | 672,388 |
Short Selling Information
The latest short interest is 8.04 million, so 13.33% of the outstanding shares have been sold short.
| Short Interest | 8.04M |
| Short Previous Month | 7.80M |
| Short % of Shares Out | 13.33% |
| Short % of Float | 15.31% |
| Short Ratio (days to cover) | 11.14 |
Income Statement
In the last 12 months, MIRM had revenue of $521.31 million and -$23.36 million in losses. Loss per share was -$0.47.
| Revenue | 521.31M |
| Gross Profit | 421.07M |
| Operating Income | -22.14M |
| Pretax Income | -21.43M |
| Net Income | -23.36M |
| EBITDA | 2.11M |
| EBIT | -22.14M |
| Loss Per Share | -$0.47 |
Full Income StatementBalance Sheet
The company has $383.33 million in cash and $319.45 million in debt, with a net cash position of $63.88 million or $1.06 per share.
| Cash & Cash Equivalents | 383.33M |
| Total Debt | 319.45M |
| Net Cash | 63.88M |
| Net Cash Per Share | $1.06 |
| Equity (Book Value) | 314.69M |
| Book Value Per Share | 6.06 |
| Working Capital | 343.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $55.83 million and capital expenditures -$954,000, giving a free cash flow of $54.87 million.
| Operating Cash Flow | 55.83M |
| Capital Expenditures | -954,000 |
| Free Cash Flow | 54.87M |
| FCF Per Share | $0.91 |
Full Cash Flow StatementMargins
Gross margin is 80.77%, with operating and profit margins of -4.25% and -4.48%.
| Gross Margin | 80.77% |
| Operating Margin | -4.25% |
| Pretax Margin | -4.11% |
| Profit Margin | -4.48% |
| EBITDA Margin | 0.40% |
| EBIT Margin | -4.25% |
| FCF Margin | 10.53% |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.63% |
| Shareholder Yield | -5.63% |
| Earnings Yield | -0.43% |
| FCF Yield | 1.01% |
Analyst Forecast
The average price target for MIRM is $114.67, which is 23.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $114.67 |
| Price Target Difference | 23.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 25.38% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 3.14 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.14 |
| Piotroski F-Score | 4 |
